GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+36.83%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$903M
AUM Growth
+$903M
(+25%)
Cap. Flow
+$5.17M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
61.67%
Holding
50
New
8
Increased
5
Reduced
11
Closed
11
Top Buys
1 |
Ascendis Pharma
ASND
|
$48.8M |
2 |
GNFT
Genfit
GNFT
|
$29.5M |
3 |
EPZM
Epizyme, Inc
EPZM
|
$26.9M |
4 |
PTC Therapeutics
PTCT
|
$22.2M |
5 |
DERM
Dermira, Inc.
DERM
|
$20.3M |
Top Sells
1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$24.7M |
2 |
Acadia Pharmaceuticals
ACAD
|
$20.2M |
3 |
Cytokinetics
CYTK
|
$20.1M |
4 |
Puma Biotechnology
PBYI
|
$18.6M |
5 |
BioCryst Pharmaceuticals
BCRX
|
$13.6M |
Sector Composition
1 | Healthcare | 97.75% |